Drug developer IGF Oncology raises $1M for clinical trials
Cancer drug developer IGF Oncology has raised $1 million in investment funding as the Minnesota startup prepares to move its drug candidate into clinical trials.
Cancer drug developer IGF Oncology has raised $1 million in investment funding as the Minnesota startup prepares to move its drug candidate into clinical trials.
With less than four weeks left in the year, Minnesota has awarded about 38 percent of the $11-million worth of angel investor tax credits available for 2010. Since launching the program in July, the state has granted about $4 million in tax credits to investors who funded startups ranging from solar energy to drugs to cancer treatments and diabetes, according to figures released this week by the Department of Employment and Economic Development.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.